Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931)

  • Jang Ho Cho
  • , Sung Hee Lim
  • , Ho Jung An
  • , Ki Hwan Kim
  • , Keon Uk Park
  • , Eun Joo Kang
  • , Yoon Hee Choi
  • , Mi Sun Ahn
  • , Myung Hee Lee
  • , Jong Mu Sun
  • , Se Hoon Lee
  • , Jin Seok Ahn
  • , Keunchil Park
  • , Myung Ju Ahn

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: Osimertinib for patients with non–small-cell lung cancer harboring uncommon EGFR mutations: A multicenter, open-label, phase II trial (KCSG-LU15-09) (Journal of Clinical Oncology (2020) DOI: 10.1200/JCO.19.00931)'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Nursing and Health Professions

Biochemistry, Genetics and Molecular Biology